Skinvisible, Inc. Files 8-K with Corporate Updates
Ticker: SKVI · Form: 8-K · Filed: Oct 3, 2024 · CIK: 1085277
| Field | Detail |
|---|---|
| Company | Skinvisible, Inc. (SKVI) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, financial-reporting
Related Tickers: SKVI
TL;DR
SKVI filed an 8-K on 10/3/24 for Reg FD and financials. Standard corporate update.
AI Summary
Skinvisible, Inc. filed an 8-K on October 3, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's status and corporate information, including its principal executive offices in Las Vegas, Nevada.
Why It Matters
This 8-K filing provides essential corporate information and disclosures for Skinvisible, Inc., which is important for investors and stakeholders to stay informed about the company's regulatory compliance and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Skinvisible, Inc. (company) — Registrant
- 0001085277 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 880344219 (company) — IRS Number
- NV (company) — State of Incorporation (Nevada)
- 702-433-7154 (company) — Business Phone Number
- October 3, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Skinvisible, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits, as indicated in the filing.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 3, 2024.
What is Skinvisible, Inc.'s Standard Industrial Classification code?
Skinvisible, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where are Skinvisible, Inc.'s principal executive offices located?
Skinvisible, Inc.'s principal executive offices are located at 6320 South Sandhill Road, Unit 9, Las Vegas, NV 89120.
What is the company's state of incorporation?
The company's state of incorporation is Nevada (NV).
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-10-03 11:21:12
Filing Documents
- skvi8k_100324.htm (8-K) — 22KB
- ex99_1v2.htm (EX-99.1) — 17KB
- 0001663577-24-000257.txt ( ) — 208KB
- skvi-20241003.xsd (EX-101.SCH) — 3KB
- skvi-20241003_lab.xml (EX-101.LAB) — 33KB
- skvi-20241003_pre.xml (EX-101.PRE) — 22KB
- skvi8k_100324_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On October 3, 2024, Skinvisible, Inc. (the "Company") issued a press release concerning an article highlighting the Company's proprietary transdermal obesity formulation development. A copy of the Company's press release is furnished as Exhibit 99.1 hereto and is incorporated by reference. The information contained in this Item, including the exhibit attached hereto, is being furnished and shall not be deemed "filed" for any purpose, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, regardless of any general incorporation language in any such filing. SECTION 9 – Financial Statements and Exhibits
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release, dated October 3, 2024 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Skinvisible, Inc. /s/ Terry Howlett Terry Howlett Chief Executive Officer Date: October 3, 2024 3